There’s a fundamental difference between Bit Bio and most other biotechnology startups. If you just need something to work once, you can find what you need with massive amounts of screening and testing — think drug...
Subscribe to the SynBioBeta Digest
Few realize it, but the bioeconomy is transforming life on Earth—from the food we eat to the medicines we take to the clothes we wear. Subscribe to the SynBioBeta weekly digest and learn the ongoing story of our planet’s most awesome technology: biology.
Editors' picks
Where Biology And Computers Combine, Trillions Await Those Who Can Scale Up: An Interview With Lattice Automation Co-Founder Doug Densmore
“Before COVID, if I said we need to reproduce or scale, people would ask, why?” says Doug Densmore, Co-Founder of Lattice Automation and Asimov. “Now, people get it.” The consequence? An automated revolution in...
U.K. Startup Just Closed $21 Million Series B To Engineer Cancer Attacking Microbes
Treating cancer is one of the biggest challenges in modern medicine. The diversity of cancer types and patient responses to therapy means that treatment is always a moving target. Though advances in chemotherapy and...
